All In Biotech

Drug Trial Radar · NCT00029861

Obese Patients With or Without Comorbidities (RIO-North America)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing and Prevention of Weight Regain Effects and Safety in Obese Patients With or Without Comorbidities

Last checked: Nov 20, 2026Latest source record: Apr 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 3,045 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,045

Actual

Start

Aug 2001

Primary completion

Apr 2004

Study completion Apr 2004

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jan 24, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities

Conditions

  • Obesity
  • Weight Loss

Interventions

  • Rimonabant (SR141716)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in body weight

Locations

51 sites in 2 countries. Site status is shown where the registry gives one.

  • Radiant Research

    Birmingham, Alabama

  • Radiant Research

    Phoenix, Arizona

  • East Bay Clinical Trial Center

    Concord, California

  • Feighner Research Institute

    San Diego, California

  • Scripps Clinic

    San Diego, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Ranch View Family Medicine

    Highlands Ranch, Colorado

  • Longmont Medical Research Network

    Longmont, Colorado

  • Health Core, Inc.

    Newark, Delaware

  • George Washington Univ. Wieght Mmgt Program

    Washington D.C., District of Columbia

  • Miami Research Associates

    Miami, Florida

  • Anchor Research Center

    Naples, Florida

  • Central Florida Clinical Solutions

    Ocoee, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Medical Dietetics, Inc.

    Atlanta, Georgia

  • Springfield Diabetes and Endocrine Center

    Springfield, Illinois

  • Medical Research Consortium

    Indianapolis, Indiana

  • Wichita Clinic, PA

    Wichita, Kansas

  • University of KY Internal Medicine

    Lexington, Kentucky

  • Pennington Center

    Baton Rouge, Louisiana

  • JM Clinical Trials, Inc.

    Swansea, Massachusetts

  • Montana Medical Research, LLC

    Missoula, Montana

  • Endocrinology and Diabetes Consultants, PC

    Dover, New Hampshire

  • Radiant Research

    Lawrenceville, New Jersey

  • Lovelace Scientific Resources

    Albuquerque, New Mexico

  • Central New York Clinical Research

    Manlius, New York

  • Comprehensive Weight Control Program

    New York, New York

  • St. Luke's Roosevelt Hospital Center

    New York, New York

  • Center for Nutrition and Preventive Medicine

    Charlotte, North Carolina

  • Multi-Specialty Research Associates of North Carolina

    Raleigh, North Carolina

  • South Dayton Research Associates

    Beavercreek, Ohio

  • Lindner Clinical Trials Center

    Cincinnati, Ohio

  • Radiant Research

    Columbus, Ohio

  • Radiant Research

    Portland, Oregon

  • SFM Clinical Trials

    Scotland, Pennsylvania

  • Radiant Research

    Wyomissing, Pennsylvania

  • ClinSearch

    Chattanooga, Tennessee

  • Clinical Research Associates, Inc

    Nashville, Tennessee

  • Radiant Research

    Austin, Texas

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.